세계의 양식용 백신 시장 규모는 2023년에 2억 1,460만 달러로 평가되며, 2024년 2억 3,091만 달러에서 2032년에는 4억 1,490만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 7.6%로 성장할 전망입니다.
세계의 양식용 백신 시장은 양식 어종에서 세균성 및 바이러스성 질병이 증가함에 따라 큰 성장이 예상되고 있습니다. 이러한 증가는 2018년 3월 비브리오증과 파스퇴렐라증에 대응하기 위해 출시된 그리스의 Icthiovac VR/PD와 같은 혁신적인 백신의 생산 및 채택 증가를 촉진하고 있습니다. 새로운 양식용 백신 개발을 위한 자금 조달은 시장 확대를 더욱 촉진하고 있으며, DNA 백신과 재조합 백신으로의 전환은 수산 식품에 대한 소비자 수요 증가와 함께 이러한 성장을 가속할 것으로 예상됩니다. 특히 조에티스(Zoetis)와 같은 기업은 매출이 13% 증가했다고 보고하고 있으며, 2016-2019년까지 양식업 분야에서 219건 이상의 감염 사례가 기록되면서 효과적인 백신 접종 솔루션에 대한 수요는 계속 증가하고 있습니다. 솔루션에 대한 수요는 계속 증가하고 있습니다.
Global Aquaculture Vaccine Market size was valued at USD 214.6 million in 2023 and is poised to grow from USD 230.91 million in 2024 to USD 414.9 million by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).
The global aquaculture vaccine market is poised for significant growth, driven by escalating bacterial and viral illnesses among aquaculture species. This rise is prompting increased production and adoption of innovative vaccines, such as Greece's Icthiovac VR/PD, launched in March 2018 to combat Vibriosis and Pasteurellosis. Enhanced funding for the development of novel aquaculture vaccines further supports market expansion. The shift towards DNA and recombinant vaccines, coupled with growing consumer demand for aquatic food products, is expected to fuel this growth. Notably, companies like Zoetis reported a 13% increase in sales, highlighting the industry's shift in focus toward essential goods. With over 219 infectious disease cases documented in the aquaculture sector from 2016 to 2019, the demand for effective vaccination solutions continues to rise.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aquaculture Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Aquaculture Vaccine Market Segmental Analysis
Global Aquaculture Vaccine Market is segmented by Product, Route of Administration, Application and region. Based on Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines and Recombinant Vaccines. Based on Route of Administration, the market is segmented into Oral, Injected and Immersion & Spray. Based on Application, the market is segmented into Bacterial, Viral, Parasitic and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Aquaculture Vaccine Market
The global aquaculture vaccine market is witnessing significant growth driven by a surge in disease outbreaks affecting seafood. Notably, incidents like the Pasteurella Skyensis outbreak in 2017, which led to the loss of approximately 125,000 salmon at farms in the Isle of Lewis, underscore the urgency for effective vaccination. Rising fish mortality rates, coupled with a growing demand for animal protein, are also propelling the need for aquaculture vaccines. Furthermore, government initiatives promoting vaccination programs and increased adoption of these vaccines in both developed and developing nations are stimulating market expansion. The global trade of aquaculture species is expected to provide additional momentum to the aquaculture vaccine market throughout the forecast period.
Restraints in the Global Aquaculture Vaccine Market
The global aquaculture vaccine market faces several constraints that may hinder its growth, primarily due to the challenges associated with handling and administering vaccines. The development of low-cost adjuvants and antigens that comply with environmental and regulatory standards can significantly affect market share, leading to reduced vaccine sales. Additionally, the requirement for highly skilled personnel to properly administer these vaccines complicates the process. Handling concerns also pose risks, including the potential for fungal infections during the vaccination process, further impeding the market's expansion and limiting the adoption of aquaculture vaccines in the industry.
Market Trends of the Global Aquaculture Vaccine Market
The Global Aquaculture Vaccine market is poised for significant growth, driven by technological advancements and an increasing incidence of aquaculture-related diseases. The rise in public-private partnerships focused on research and development fosters innovation, while enhanced diagnostic and therapeutic options in developing regions bolster product offerings. Additionally, rising per capita healthcare spending further propels market expansion. The emergence of strategic alliances and heightened internet connectivity also contribute to the sector's dynamism. Concerns regarding zoonotic diseases and their transmission from aquatic animals to humans are underscoring the urgency of advancing vaccine solutions, thereby solidifying the market's upward trajectory through 2023 and beyond.